Abstract Since the comprehensive recommendations for the management of acute promyelocytic leukemia (APL) reported in 2009, several studies have provided important insights, particularly regarding the role of arsenic trioxide (ATO) in frontline therapy. Ten years later, a European LeukemiaNet expert...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!